Induction chemotherapy stategies for primary mediastinal large B-cell lymphoma with sclerosis: A retrospective multinational study on 426 previously untreated patients

Haematologica

Volumn 87, Issue 12, 2002, Pages 1258-1264

  Zinzani, Pier Luigi ^a   Martelli, Maurizio ^b   Bertini, Marilena ^b   Gianni, Alessandro M ^b   Devizzi, Liliana ^b   Federico, Massimo ^b   Pangalis, Gerassimos ^b   Michels, Jorg ^b   Zucca, Emanuele ^b   Cantonetti, Maria ^b   Cortelazzo, Sergio ^b   Wotherspoon, Andrew ^b   Ferreri, Andrés J M ^b   Zaja, Francesco ^b   Lauria, Francesco ^b   De Renzo, Amalia ^b   Liberati, Marina A ^b   Falini, Brunangelo ^b   Balzarotti, Monica ^b   Calderoni, Antonello ^b   Zaccaria, Alfonso ^b   Gentilini, Patrizia ^b   Fattori, Pier Paolo ^b   Pavone, Enzo ^b   Angelopoulou, Maria K ^b   Alinari, Lapo ^b   Brugiatelli, Maura ^b   Di Renzo, Nicola ^b   Bonifazi, Francesca ^b   Pileri, Stefano A ^b   Cavalli, Franco ^b   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

Chemotherapy; Combined modality treatment; PMLBCL; Radiotherapy; Response rate

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; MALE; MEDIASTINUM CANCER; MULTICENTER STUDY; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; SCLEROSIS; SURVIVAL RATE; ADOLESCENT; HISTIOCYTIC LYMPHOMA; MEDIASTINUM TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; REMISSION; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SCLEROSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036906427     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
2. Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol 1986; 10:176-91.
3. Menestrina F, Chilosi M, Bonetti F, Lestani M, Scarpa A, Novelli, et al. Mediastinal large-cell lymphoma of B-type, with sclerosis: Histopathological and immunohistochemical study of eight cases. Histopathology 1986; 10:589-600.
4. Paulli M, Lazzarino M, Gianelli U, Strater E, Orlandi E, Klersy C, et al. Primary mediastinal B-cell lymphoma: Update of its clinicopathologic features. Leuk Lymphoma 1997; 26 Suppl 1:115-23.
5. Aisenberg AC. Primary large-cell lymphoma of the mediastinum. J Clin Oncol 1993; 11:2291-8.
6. Kirn D, Mauch P, Shaffer K, Pinkus G. Shipp MA, Kaplan WD, et al. Large-cell and immunoblastic lymphoma of the mediastinum prognostic features and treatment outcome in 57 patients. J Clin Oncol 1993; 11:1336-43.
7. Haioun C, Gaulard P, Roudot-Thoraval F, Divine M, Jouault H, Lebourgeois JP, et al. Mediastinal diffuse large-cell lymphoma with sclerosis: A condition with a poor prognosis. Am J Clin Oncol 1989; 12:425-9.
8. Jacobson JO, Aisenberg AC, Lamarre L, Willett CG Linggood RM, Miketic LM, et al. Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 1988; 62:1893-8.
9. Rodriguez J, Pugh WC, Romaguera JE, Cabanillas F. Primary mediastinal large cell lymphoma. Hematol Oncol 1994; 12:175-84.
10. Abou-Elella AA, Weisenburger DD, Vose JM, Kollath JP, Lynch JC, Bast MA, et al. Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol 1999; 17:784-90.
11. Nguyen LN, Ha CS, Hess M, Romaguera JE, Manning JT, Cabanillas F, et al. The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum. Int J Radiat Oncol Biol Phys 2000; 47:1281-5.
12. Falini B, Venturi S, Martelli M, Santucci A, Pileri S, Pescarmona E, et al. Mediastinal large B-cell lymphoma: Clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 1995; 89:780-9.
13. Lazzarino M, Orlandi E, Paulli M, Boveri E, Morra E, Brusamolino E, et al. Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 1993; 11:2306-13.
14. Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d'Agay MF, Baumelou E, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 1996; 20:877-88.
15. Todeschini G, Ambrosetti A, Meneghini V, Pizzolo G, Menestrina F, Chilosi M, et al. Mediastinal large-B-cell lymphoma with sclerosis: A clinical study of 21 patients. J Clin Oncol 1990; 8:804-8.
16. Bertini M, Orsucci L, Vitolo U, Levis A, Todeschini G, Meneghini V, et al. Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol 1991; 2:733-7.
17. Zinzani PL, Bendandi M, Frezza G, Gherilnzoni F, Merla E, Salvucci M, et al. Primary mediastinal B-cell lymphoma with sclerosis: Clinical and therapeutic evaluation of 22 patients. Leuk Lymphoma 1996; 21:311-6.
18. Lazzarino M, Orlandi E, Paulli M, Strater J, Klersy C, Gianelli U, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients. J Clin Oncol 1997; 15:1646-53.
19. Martelli MP, Martelli M, Pescarmona E, De Sanctis V, Donato V, Palombi F, et al. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol 1998; 9:1027-9.
20. Zinzani PL, Martelli M, Magagnoli M, Pescarmona E, Scaramucci L, Palombi F, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by 67Galli um scan in 50 patients. Blood 1999; 94:3289-93.
21. Popat U, Przepiork D, Champlin R, Pugh W, Amin K, Mehra R, et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome. J Clin Oncol 1998; 16:63-9.
22. Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, et al. Primary diffuse large B-cell lymphoma of the mediastinum: Outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood 1998; 91:717-23.
23. Nademanee A, Molina A, O'Donnell MR, Dagis A, Snyder DS, Parker P, et al. Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: International index high and high-intermediate risk group. Blood 1997; 90:3844-52.
24. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328:1002-6.
25. Zinzani PL, Magagnoli M, Franchi R, Zompatori M, Frezza G, Galassi R, et al. Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement. Haematologica 1999; 84:604-7.
26. Zinzani PL, Martelli M, Bendandi M, De Renzo A, Zaccaria A, Pavone E, et al. Primary mediastinal large B-cell lymphoma with sclerosis: A clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica 2001; 86:187-91.
27. Bieri S, Roggero E, Zucca E, Bertoni F, Pianca S, Sanna P, et al. Primary mediastinal large B-cell lymphoma (PMLCL): The need for prospective controlled clinical trials. Leuk Lymphoma 1999; 35:139-46.
28. Carbone PP, Kaplan HS, Musshoff K, Smithers DW Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31:1860-1.
29. Anonymous. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329:987-94.
30. McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, et al. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38:1484-93.
31. Rodriguez V, Cabanillas F, Burgess MA, McKelvey EM, Valdivieso M, Bodey GP, et al. Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma. Blood 1977; 49:325-33.
32. Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 1985; 102:596-602.
33. O'Reilly SE, Hoskins P, Klimo P, Connors JM. MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease. Ann Oncol 1991; 2 Suppl 1:17-23.
34. Fisher RI, DeVita VT Jr, Hubbard SM, Simon R, Young RC. Randomized trial of Pro-MACE-MOPP vs. ProMACE-CytaBOM in previously untreated, advanced stage, diffuse aggressive lymphomas. Proc Am Soc Clin Oncol 1984; 3:242.
35. Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 336:1290-7.
36. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53:457-81.
37. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1-39.
38. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc 1972; 34:187-220.
39. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10:1419-32.
40. Van Besien K, Kelta M, Bahaguna P. Primary mediastinal B-cell lymphoma: A review of pathology and management. J Clin Oncol 2001; 19:1855-64.
41. Guglielmi C, Amadori S, Anselmo AP, Baroni CD, Biagini C, Cimino G, et al. Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP). Cancer Invest 1987; 5:159-69.
42. Zinzani PL, Zompatori M, Bendandi M, Battista G, Fanti S, Barbieri E, et al. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. Leuk Lymphoma 1996; 22:131-5.
43. Front D, Israel O. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Sem Nucl Med 1995; 25:60-71.